A Review of Omacetaxine: A Chronic Myeloid Leukemia Treatment Resurrected

Oncology and Therapy - Switzerland
doi 10.1007/s40487-018-0058-6
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Nilotinib for the Treatment of Chronic Myeloid Leukemia: An Evidence-Based Review

Core Evidence
MedicineReviewsReferencesPharmacology
2009English

A Typical Atypical Chronic Myeloid Leukemia

Clinical Case Reports
Medicine
2018English

Treatment-Related Acute Myeloid Leukemia in a Chronic Lymphocytic Leukemia Patient: Role of Fludarabine?

Therapeutic Advances in Hematology
Hematology
2015English

A Prisoner With Chronic Myeloid Leukemia

Bone Marrow Transplantation
TransplantationHematology
1999English

Gynecomastia in a Male After Dasatinib Treatment for Chronic Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Chronic Myeloid Leukemia

2020English

Chronic Myeloid Leukemia

Hematologic Malignancies
2016English

Leukemia Cutis in a Patient With Chronic Myeloid Leukemia

IOSR Journal of Dental and Medical Sciences
2014English

Inhibitory Effects of Omacetaxine on Leukemic Stem Cells and BCR-ABL-induced Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Mice

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy